THE SIGNIFICANCE OF QUANTITATIVE DATA FROM PET/CT IN THE COURSE OF SARCOIDOSIS AND THEIR ASSOCIATION WITH CLINICAL PARAMETERS
Open Access
- 26 April 2025
- journal article
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 27 (1) , 22-28
Abstract
Objectives: To examine the potential correlation between the presence of a disease outside the chest and the likelihood of recurrence or need for therapy, as well as to assess the relationship between quantitative measurements obtained from 18F-FDG PET/CT scans and clinical and laboratory markers associated with sarcoidosis. Material and Methods: 18F-FDG PET/CT images of 78 patients diagnosed with sarcoidosis were retrospectively examined. The SUV max value of the lesions with the highest uptake in the thoracic and extrathoracic regions of the disease was determined. Clinical and laboratory parameters, and SUV max values of the lesions were compared. The relationship between the detection of an extrathoracic disease and the need for treatment, and the development of recurrence was also investigated. Results: No significant correlation was found between patients with thoracic and extrathoracic disease regarding SUVmax and clinical and laboratory results (p>0.05). A significant correlation was detected between the SUVmax value of mediastinal lymph nodes and the presence of extrathoracic disease (pKeywords
This publication has 19 references indexed in Scilit:
- Severity of pulmonary involvement and 18F-FDG PET activity in sarcoidosisRespiratory Medicine, 2013
- Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosisRespiratory Medicine, 2011
- 18F-FDG PET/CT detects systemic involvement in sarcoidosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- 18F-FDG PET/CT for the diagnosis of sarcoidosis in a patient with bilateral inflammatory involvement of the parotid and lacrimal glands (panda sign) and bilateral hilar and mediastinal lymphadenopathy (lambda sign)European Journal of Nuclear Medicine and Molecular Imaging, 2011
- 18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- 18F-FDG PET/CT in sarcoidosis management: review and report of 20 casesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammationSeminars in Nuclear Medicine, 2002
- ATS/ERS/WASOG statement on sarcoidosisEuropean Respiratory Journal, 1999
- Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosisThe American Journal of Medicine, 1975